Adverse events in renal transplantation under tacrolimus/mycophnolate mofetil immunosuppression: a single-center experience.
Omoto
K
K
Department of Urology, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Tanabe
K
K
Tokumoto
T
T
Ishida
H
H
Shimmura
H
H
Makiyama
K
K
Toma
H
H
D000017:ABO Blood-Group System; D000328:Adult; D001787:Blood Group Incompatibility; D005260:Female; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects*
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus; D008775:Methylprednisolone